Elevance Health (NYSE:ELV – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 37.100- for the period, compared to the consensus estimate of 37.050. The company issued revenue guidance of -. Analyst Ratings Changes Several research analysts have commented on the stock. Morgan Stanley […]
Assenagon Asset Management S.A. lifted its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 212.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 366,833 shares of the company’s stock after purchasing an additional 249,533 shares during the […]
US Bancorp DE cut its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 12.0% in the third quarter, Holdings Channel reports. The institutional investor owned 58,065 shares of the company’s stock after selling 7,913 shares during the period. US Bancorp DE’s holdings in Elevance Health were worth $24,958,000 at the end of the […]
US Bancorp DE lessened its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 12.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 58,065 shares of the company’s stock after selling 7,913 shares during the period. US Bancorp DE’s holdings in […]
Canoe Financial LP grew its holdings in Elevance Health, Inc. (NYSE:ELV – Free Report) by 79.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 327,006 shares of the company’s stock after buying an additional 144,422 shares during the period. […]